Publication | Open Access
Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)
94
Citations
12
References
2017
Year
Our data suggest that RTX is an effective and safe therapeutic option for adult-onset IgAV.
| Year | Citations | |
|---|---|---|
Page 1
Page 1